PLoS ONE (Jan 2023)

Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol

  • Anouk W. M. A. Schaeffers,
  • Lot A. Devriese,
  • Carla H. van Gils,
  • Jan Willem Dankbaar,
  • Jens Voortman,
  • Jan Paul de Boer,
  • Marije Slingerland,
  • Mathijs P. Hendriks,
  • Ernst J. Smid,
  • Geert W. J. Frederix,
  • Remco de Bree

Journal volume & issue
Vol. 18, no. 11

Abstract

Read online

No abstracts available.